Transcatheter arterial chemical infusion for advanced non-small-cell lung cancer: long-term outcome and predictor of survival
Author:
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11547-016-0629-2.pdf
Reference20 articles.
1. Chambers SK, Dunn J, Occhipinti S et al (2012) A systematic review of the impact of stigma and nihilism on lung cancer outcomes. BMC Cancer 12:184
2. Ostroff JS, Krebs P, Coups EJ et al (2011) Health-related quality of life among early-stage, non-small cell, lung cancer survivors. Lung Cancer 71:103–108
3. Furukawa K, Ishida J, Yamaguchi G et al (2010) The role of airway stent placement in the management of tracheobronchial stenosis caused by inoperable advanced lung cancer. Surg Today 40:315–320
4. Nakanishi M, Yoshida Y, Natazuka T (2012) Prospective study of transarterial infusion of docetaxel and cisplatin to treat non-small-cell lung cancer in patients contraindicated for standard chemotherapy. Lung Cancer 77:353–358
5. Nakanishi M, Umeda Y, Demura Y et al (2007) Effective use of multi-arterial infusion chemotherapy for advanced non-small cell lung cancer patients: four clinical specified cases. Lung Cancer 55:241–247
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lung and Mediastinal Cancer;Multimodality Imaging and Intervention in Oncology;2023
2. Clinical outcomes of vinorelbine loading CalliSpheres beads in the treatment of previously treated advanced lung cancer with progressive refractory obstructive atelectasis;Frontiers in Bioengineering and Biotechnology;2022-12-20
3. Transarterial Treatment of Lung Cancer;Life;2022-07-19
4. Drug-Eluting Bead Bronchial Arterial Chemoembolization With and Without Microwave Ablation for the Treatment of Advanced and Standard Treatment-Refractory/Ineligible Non-Small Cell Lung Cancer: A Comparative Study;Frontiers in Oncology;2022-03-15
5. Bronchial artery chemoembolization with apatinib for treatment of central lung squamous cell carcinoma;Journal of Cancer Research and Therapeutics;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3